Ken Bartizal serves as Executive at Trius Therapeutics Inc, where they oversee executive responsibilities. Since joining the company, Ken Bartizal has executed 7 insider transactions totaling $328.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 11, 2013 involved selling 96,400 shares valued at $0.
Ken Bartizal currently holds 95,300 shares of Trius Therapeutics Inc (TSRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ken Bartizal has been a net seller of TSRX stock. They have purchased $0 and sold $328.9K worth of shares.
Ken Bartizal's most recent insider trade was on Sep 11, 2013, when they sold 96,400 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.14 |
| Discretionary |
| Jun 4, 2013 | TSRX | $15.8K | Sale | 2,000 | $7.90 | Discretionary |
| May 24, 2013 | TSRX | $95.2K | Sale | 12,000 | $7.93 | Discretionary |
| May 14, 2013 | TSRX | $94.2K | Sale | 12,000 | $7.85 | Discretionary |
| May 14, 2013 | TSRX | $94.2K | Sale | 12,000 | $7.85 | Discretionary |
| Nov 17, 2011 | TSRX | $13.2K | Sale | 1,687 | $7.85 | Discretionary |